Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment interruptions

HIV Viral load at Diagnosis Predicts Time to Rebound After Treatment Interruption

Editor's pick
Infectious Disease Advisor
26 August 2022
New & experimental HIV treatments

European Commission approves first twice-yearly HIV medication

News
25 August 2022
HIV treatment

Best-in-class second-line HIV treatment rolls out in Zambia and Nigeria

Editor's pick
Clinton Health Access Initiative
25 August 2022
HIV treatment for children & young people

South Africa puts child-friendly ARV treatment on hold

Editor's pick
Health-e
24 August 2022
Bone & joint problems

Vitamin D and calcium supplements suggested to avert bone disease in people taking tenofovir-based ART and PrEP

News
24 August 2022
Injectable & long-acting HIV treatment

UNAIDS responds to EU approval of a long acting HIV treatment option: “To end AIDS, share technology.”

Editor's pick
UNAIDS
23 August 2022
Injectable & long-acting HIV treatment

Long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression

News
23 August 2022
Pharmaceutical industry

Gilead bags first approval for twice-yearly HIV therapy

Editor's pick
Pharmaphorum
22 August 2022
The search for a cure

A cure must be a cure for all: why more HIV cure research in Africa is needed

News
22 August 2022
Weight gain & lipodystrophy

Dutch study explores issue of weight gain with changes in HIV treatment

Editor's pick
CATIE News
18 August 2022
Access to healthcare

Uganda: Lifesaving HIV/Aids Medication Runs Out of Stock, CSOs Warn

Editor's pick
AllAfrica
17 August 2022
Adherence

Providing ‘fast-track’ HIV treatment refills improves adherence

Editor's pick
Be In The Know
17 August 2022
Pregnancy and vertical transmission

Traditional, alternative HIV regimens yield similar results in pregnancy

Editor's pick
Healio
11 August 2022
Coronavirus

Major Update to the COVID-19 Treatment Guidelines

Editor's pick
HIV.gov
11 August 2022
Access to healthcare

HIV patients in India protest shortage of drugs

Editor's pick
Deutsche Welle
10 August 2022
Injectable & long-acting HIV treatment

Long-Acting Injectable HIV Therapy for People Who Won’t Take ART?

Editor's pick
NEJM Journal Watch
10 August 2022
Treatment outcomes & life expectancy

Immune Recovery, Integrase Inhibitors Improve Survival for People With Late HIV Diagnosis

Editor's pick
POZ
9 August 2022
Child developmental issues

Differences in Early Growth Small for ART-Conceived Infants

Editor's pick
HealthDay News
9 August 2022
Injectable & long-acting HIV treatment

New formulations and alternative injection sites might allow self-administration of long-acting cabotegravir and rilpivirine

News
9 August 2022
Treatment outcomes & life expectancy

Biktarvy Shows Durable Viral Suppression After 5 Years

Editor's pick
Infectious Disease Special Edition
5 August 2022
Weight gain & lipodystrophy

Switching From Integrase Inhibitor to PI Trims Weight in HIV Patient Database

Editor's pick
NATAP
5 August 2022
Treatment simplification strategies

Macrophage Activation for 2 Years After Switch From 3 to 2 Antiretrovirals

Editor's pick
NATAP
5 August 2022
Mental & emotional health & wellbeing

Lonely People With HIV Are More Likely to Skip Treatment

Editor's pick
POZ
3 August 2022
HIV treatment

Dolutegravir Around the World: Outcomes in Advanced AIDS and Maintenance Therapy

Editor's pick
TheBodyPro
2 August 2022